SLC16A1 and cancer: In the absence of changes in the expression of MCT1, MCT2, MCT4 and CD147/basigin, residual lactate uptake could be explained by the relatively higher basal expression of MCT2 in cancer versus nonmalignant cells (Figure S1B).